What is the appropriate evaluation and management for hypoactive sexual desire in men?

Hypoactive Sexual Desire in Men: Evaluation and Management

Men with hypoactive sexual desire should be evaluated for low testosterone levels (total testosterone <300 ng/dL), and if confirmed on repeat testing with accompanying symptoms, testosterone therapy should be offered to improve libido. 1

Diagnostic Approach

Initial Screening and Assessment

Measure morning serum total testosterone using an accurate assay in men presenting with decreased sexual desire, reduced sexual fantasies, or diminished sexual activity 2. The threshold for hypogonadism is total testosterone <300 ng/dL (10.4 nmol/liter) 1.

Key diagnostic steps:

• Confirm low testosterone on at least two separate morning measurements before initiating treatment 1
• If total testosterone is borderline, check sex hormone-binding globulin (often low in diabetes and associated with lower testosterone) 2
• Measure LH and FSH to differentiate primary from secondary hypogonadism 3
• Check prolactin levels to exclude hyperprolactinemia (can suppress gonadotropins and cause sexual dysfunction even with normal testosterone) 3

Critical Exclusions Before Treatment

Mandatory baseline assessments before testosterone therapy 1, 3:

• Digital rectal examination of prostate
• PSA level (obtain urological consultation if PSA >0.6 ng/mL)
• Hematocrit (baseline and at 3-6 months)
• Screen for prostate cancer, breast cancer, sleep apnea, and polycythemia

Absolute contraindications to testosterone therapy: prostate cancer and breast cancer 3

Relative contraindications requiring careful consideration: sleep apnea, peripheral edema, erythrocytosis (hematocrit >52%), and benign prostatic hyperplasia 3

Differential Diagnosis Beyond Testosterone

Evaluate for other endocrine disorders that cause low libido 3:

• Hyperprolactinemia (from medications, hypothyroidism, pituitary tumors, or chest wall injuries)
• Thyroid disorders (both hypothyroidism and hyperthyroidism)
• Adrenal disorders (insufficiency or excess corticosteroids)
• Poorly controlled diabetes (check HbA1c; improved glycemic control may restore function)

Screen for depression and anxiety using validated tools like HADS, as these commonly coexist with and contribute to low sexual desire 3, 4. Antidepressant medications themselves frequently impair sexual function 3.

Assess relationship factors and psychosocial stressors, as these independently contribute to hypoactive sexual desire disorder even when testosterone is normal 5, 6.

Treatment Algorithm

For Men with Confirmed Low Testosterone (<300 ng/dL) and Low Libido

Testosterone replacement therapy is recommended 1, 7. Evidence shows large improvements in libido in randomized trials, though results are somewhat inconsistent 1, 7.

Recommended testosterone regimens 7:

• Intramuscular: 75-100 mg testosterone enanthate or cypionate weekly, OR 150-200 mg every 2 weeks
• Transdermal patches: One or two 5-mg patches applied nightly to back, thigh, or upper arm
• Testosterone gel: 5-10 g applied daily (advise covering application site with shirt and washing before skin-to-skin contact to prevent transfer) 1
• Buccal tablets: 30 mg applied to buccal mucosa twice daily

Monitoring During Testosterone Therapy

Follow-up schedule 1, 3:

• At 1-3 months: Check testosterone level, hematocrit, PSA, digital rectal exam, assess symptom improvement
• At 6 months: Repeat above assessments
• Ongoing: Every 6-12 months thereafter

Obtain urgent urological consultation if 1:

• PSA increases >1.4 ng/mL within any 12-month period
• PSA velocity >0.4 ng/mL/year (using 6-month level as reference)
• Prostatic abnormality on digital rectal examination
• AUA/IPSS symptom score >19

For Men with Normal Testosterone or Borderline Levels

The evidence for testosterone therapy in men with testosterone >300 ng/dL is weak and shows no significant benefit 7. Do not routinely offer testosterone to older men with low-normal testosterone levels 1.

Instead, address:

1. Psychological factors: Consider cognitive-behavioral therapy, sex therapy, or couples therapy for relationship issues 3, 6
2. Medical comorbidities: Optimize diabetes control, manage hypertension, treat hyperlipidemia, encourage tobacco cessation 3
3. Medication review: Identify and modify drugs causing sexual dysfunction (antidepressants, antihypertensives) 3
4. Treat hyperprolactinemia if present (dopamine agonists like cabergoline) 3

Important Clinical Pitfalls

Avoid these common errors:

• Starting testosterone without confirming low levels on repeat testing
• Failing to screen for prostate cancer before initiating therapy
• Ignoring cardiovascular risk (testosterone in older men with hypogonadism has been associated with increased coronary plaque volume and cardiovascular events) 2
• Overlooking depression and relationship factors that may be primary drivers
• Treating all older men with age-related testosterone decline (this is controversial and not recommended as general policy) 1

Special Considerations

In men with erectile dysfunction AND low testosterone: Evaluate and treat underlying ED causes first, consider established ED therapies (PDE5 inhibitors), then add testosterone if levels are unequivocally low 1. Note that androgen deficiency and ED are independently distributed disorders with distinct pathophysiology 1.

Older men: Treatment decisions require explicit discussion of uncertain long-term safety, unclear benefits, and potential cardiovascular risks 1, 2. Individualize based on severity of symptoms and patient preference after shared decision-making.

Men with diabetes: Hypogonadism is common in this population 3. Improved glycemic control may restore function in recently diagnosed diabetes, but less likely after >10 years duration with established neuropathy 3.